Gaffney A, Himmelstein DU, Woolhandler S
Meanwhile, risks could still develop with longer term GLP-1 receptor agonist use
Hazard ratio in clinical trials
[31] Proportions of side effects were not noted in the phase 2 study, but results from an earlier phase 1 study, with 8 obese patients receiving weekly Mazdutide (9 mg) showed side effects of nausea (62.5% of patients), diarrhea (25%) and vomiting (37.5%) were seen after 12 weeks [32] , although it must be noted that these numbers probably deviate largely from the results in the phase 2 study, simply due to sheer differences in sample sizes
BPC-157 is a high-purity, research-grade synthetic peptide designed exclusively for advanced laboratory investigation, particularly within tissue biology and regenerative science research domains